Therefore, our studies provide a novel insight into the role of CD26+CD8+ T cells in CLL patients and suggest that CD26highCD8+ T cells may have promising potential for adoptive T cell transfer and CAR T cell therapies. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.